A Chemical Probe that Labels Human Pluripotent Stem Cells

Cell Reports

Volumn 6, Issue 6, 2014, Pages 1165-1174

  Hirata, Nao ^a,b   Nakagawa, Masato ^c   Fujibayashi, Yuto ^b   Yamauchi, Kaori ^d   Murata, Asako ^a,b   Minami, Itsunari ^a   Tomioka, Maiko ^a   Kondo, Takayuki ^c   Kuo, Ting Fang ^a,b   Endo, Hiroshi ^c,g   Inoue, Haruhisa ^c   Sato, Shin Ichi ^a,b   Ando, Shin ^a,b   Kawazoe, Yoshinori ^b   Aiba, Kazuhiro ^a   Nagata, Koh ^a   Kawase, Eihachiro ^d   Chang, Young Tae ^e,f   Suemori, Hirofumi ^d   Eto, Koji ^c   Nakauchi, Hiromitsu ^g   Yamanaka, Shinya ^a,c   Nakatsuji, Norio ^a,d   Ueda, Kazumitsu ^a,b   Uesugi, Motonari ^a,b   more..

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f AGENCY FOR SCIENCE   (Singapore)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CELL MARKER; FLUORESCENT DYE; KYOTO PROBE 1; MULTIDRUG RESISTANCE PROTEIN 1; RETINOID; STAGE SPECIFIC EMBRYO ANTIGEN 4; UNCLASSIFIED DRUG; MOLECULAR PROBE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; KRUPPEL LIKE FACTOR 4; ORGANIC CATION TRANSPORTER 3; RHODAMINE; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EFFUSION; EMBRYONIC STEM CELL; FEEDER CELL; FLOW CYTOMETRY; GENE REPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MITOCHONDRION; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; SOMATIC CELL; ANIMAL; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; HEK293 CELL LINE; MOLECULAR PROBE; MOUSE; PROCEDURES; ANIMAL CELL; CELL CULTURE; CONTACT INHIBITION; EXPRESSION VECTOR; FLAME PHOTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HYDROPHOBICITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; FLUORESCENT DYES; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBES; PLURIPOTENT STEM CELLS;

EID: 84897101263     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.02.006     Document Type: Article

References (51)

1. Ahlin G., Hilgendorf C., Karlsson J., Szigyarto C.A., Uhlén M., Artursson P. Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab. Dispos. 2009, 37:2275-2283.
2. Ahn Y.H., Lee J.S., Chang Y.T. Combinatorial rosamine library and application to invivo glutathione probe. J.Am. Chem. Soc. 2007, 129:4510-4511.
3. Allen J.D., van Loevezijn A., Lakhai J.M., van der Valk M., van Tellingen O., Reid G., Schellens J.H.M., Koomen G.J., Schinkel A.H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter invitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 2002, 1:417-425.
4. Apáti A., Orbán T.I., Varga N., Németh A., Schamberger A., Krizsik V., Erdélyi-Belle B., Homolya L., Várady G., Padányi R., et al. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim. Biophys. Acta 2008, 1778:2700-2709.
5. Ben-Shushan E., Sharir H., Pikarsky E., Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol. Cell. Biol. 1995, 15:1034-1048.
6. Bernardo A.S., Faial T., Gardner L., Niakan K.K., Ortmann D., Senner C.E., Callery E.M., Trotter M.W., Hemberger M., Smith J.C., et al. BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell 2011, 9:144-155.
7. Bortell R., van Wijnen A.J., Ramsey-Ewing A.L., Stein G.S., Stein J.L. Differential regulation of H4 histone gene expression in 3T3-L1 pre-adipocytes during arrest of proliferation following contact inhibition or differentiation and its modulation by TGF beta 1. J.Cell. Biochem. 1992, 50:62-72.
8. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
9. Chen Z.S., Aoki S., Komatsu M., Ueda K., Sumizawa T., Furukawa T., Okumura H., Ren X.Q., Belinsky M.G., Lee K., et al. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. Int. J. Cancer 2001, 93:107-113.
10. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3:127-133.
11. Greenfield N.J., Pietruszko R. Two aldehyde dehydrogenases from human liver. Isolation via affinity chromatography and characterization of the isozymes. Biochim. Biophys. Acta 1977, 483:35-45.
12. Henderson J.K., Draper J.S., Baillie H.S., Fishel S., Thomson J.A., Moore H., Andrews P.W. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 2002, 20:329-337.
13. Heytler P.G. Uncoupling of oxidative phosphorylation by carbonyl cyanide phenylhydrazones 0.1. Some characteristics of M-Cl-Ccp action on mitochondria and chloroplasts. Biochemistry 1963, 2:357-361.
14. Im C.N., Kang N.Y., Ha H.H., Bi X.Z., Lee J.J., Park S.J., Lee S.Y., Vendrell M., Kim Y.K., Lee J.S., et al. A fluorescent rosamine compound selectively stains pluripotent stem cells. Angew. Chem. Int. Ed. Engl. 2010, 49:7497-7500.
15. Kasianowicz J., Benz R., McLaughlin S. The kinetic mechanism by which CCCP (carbonyl cyanide m-chlorophenylhydrazone) transports protons across membranes. J.Membr. Biol. 1984, 82:179-190.
16. Kawazoe Y., Shimogawa H., Sato A., Uesugi M. A mitochondrial surface-specific fluorescent probe activated by bioconversion. Angew. Chem. Int. Ed. Engl. 2011, 50:5478-5481.
17. Kim Y.K., Lee J.S., Bi X.Z., Ha H.H., Ng S.H., Ahn Y.H., Lee J.J., Wagner B.K., Clemons P.A., Chang Y.T. The binding of fluorophores to proteins depends on the cellular environment. Angew. Chem. Int. Ed. Engl. 2011, 50:2761-2763.
18. Langmann T., Mauerer R., Zahn A., Moehle C., Probst M., Stremmel W., Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin. Chem. 2003, 49:230-238.
19. Mann M., Hendrickson R.C., Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 2001, 70:437-473.
20. Minami I., Yamada K., Otsuji T.G., Yamamoto T., Shen Y., Otsuka S., Kadota S., Morone N., Barve M., Asai Y., et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2012, 2:1448-1460.
21. Minamikawa T., Sriratana A., Williams D.A., Bowser D.N., Hill J.S., Nagley P. Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. J.Cell Sci. 1999, 112:2419-2430.
22. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
23. Moitra K., Dean M. Evolution of ABC transporters by gene duplication and their role in human disease. Biol. Chem. 2011, 392:29-37.
24. Morizane A., Doi D., Kikuchi T., Nishimura K., Takahashi J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J.Neurosci. Res. 2011, 89:117-126.
25. Nagata K., Nishitani M., Matsuo M., Kioka N., Amachi T., Ueda K. Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. J.Biol. Chem. 2000, 275:17626-17630.
26. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
27. Niwa H., Toyooka Y., Shimosato D., Strumpf D., Takahashi K., Yagi R., Rossant J. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005, 123:917-929.
28. Pesce M., Schöler H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001, 19:271-278.
29. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W.J., Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-692.
30. Schnerch A., Cerdan C., Bhatia M. Distinguishing between mouse and human pluripotent stem cell regulation: the best laid plans of mice and men. Stem Cells 2010, 28:419-430.
31. Shamblott M.J., Axelman J., Wang S.P., Bugg E.M., Littlefield J.W., Donovan P.J., Blumenthal P.D., Huggins G.R., Gearhart J.D. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 1998, 95:13726-13731.
32. Suemori H., Yasuchika K., Hasegawa K., Fujioka T., Tsuneyoshi N., Nakatsuji N. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem. Biophys. Res. Commun. 2006, 345:926-932.
33. Svensson R., Grenö C., Johansson A.S., Mannervik B., Morgenstern R. Synthesis and characterization of 6-chloroacetyl-2-dimethylaminonaphthalene as a fluorogenic substrate and a mechanistic probe for glutathione transferases. Anal. Biochem. 2002, 311:171-178.
34. Taguchi Y., Kino K., Morishima M., Komano T., Kane S.E., Ueda K. Alteration of substrate specificity by mutations at the His(61) position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. Biochemistry 1997, 36:8883-8889.
35. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
36. Takayama N., Nishikii H., Usui J., Tsukui H., Sawaguchi A., Hiroyama T., Eto K., Nakauchi H. Generation of functional platelets from human embryonic stem cells invitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 2008, 111:5298-5306.
37. Takayama N., Nishimura S., Nakamura S., Shimizu T., Ohnishi R., Endo H., Yamaguchi T., Otsu M., Nishimura K., Nakanishi M., et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J.Exp. Med. 2010, 207:2817-2830.
38. Tamai I., Safa A.R. Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. J.Biol. Chem. 1990, 265:16509-16513.
39. Tanabe K., Nakamura M., Narita M., Takahashi K., Yamanaka S. Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc. Natl. Acad. Sci. USA 2013, 110:12172-12179.
40. Tang L., Bergevoet S.M., Gilissen C., de Witte T., Jansen J.H., van der Reijden B.A., Raymakers R.A. Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells. BMC Pharmacol. 2010, 10:12.
41. Tang C., Lee A.S., Volkmer J.P., Sahoo D., Nag D., Mosley A.R., Inlay M.A., Ardehali R., Chavez S.L., Pera R.R., et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat. Biotechnol. 2011, 29:829-834.
42. Thomson J.A., Kalishman J., Golos T.G., Durning M., Harris C.P., Becker R.A., Hearn J.P. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 1995, 92:7844-7848.
43. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
44. Uchida N., Dykstra B., Lyons K., Leung F., Kristiansen M., Eaves C. ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status. Blood 2004, 103:4487-4495.
45. Ueda K. ABC proteins protect the human body and maintain optimal health. Biosci. Biotechnol. Biochem. 2011, 75:401-409.
46. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 1987, 84:3004-3008.
47. Versantvoort C.H.M., Bagrij T., Wright K.A., Twentyman P.R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer 1995, 63:855-862.
48. Wang H.M., Hao J.J., Hong C.C. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signaling. ACS Chem. Biol. 2011, 6:192-197.
49. Young J., Holland I.B. ABC transporters: bacterial exporters-revisited five years on. Biochim. Biophys. Acta 1999, 1461:177-200.
50. Zeng H., Park J.W., Guo M., Lin G., Crandall L., Compton T., Wang X.F., Li X.J., Chen F.P., Xu R.H. Lack of ABCG2 expression and side population properties in human pluripotent stem cells. Stem Cells 2009, 27:2435-2445.
51. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 2001, 7:1028-1034.